Financhill
Sell
40

MDLYF Quote, Financials, Valuation and Earnings

Last price:
$14.24
Seasonality move :
--
Day range:
$14.24 - $14.24
52-week range:
$14.24 - $22.84
Dividend yield:
0%
P/E ratio:
42.74x
P/S ratio:
1.95x
P/B ratio:
4.05x
Volume:
--
Avg. volume:
12
1-year change:
-37.65%
Market cap:
$446.8M
Revenue:
$193.4M
EPS (TTM):
$0.33

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Medley, Inc. has -- downside to fair value with a price target of -- per share.

MDLYF vs. S&P 500

  • Over the past 5 trading days, Medley, Inc. has underperformed the S&P 500 by -0.31% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Medley, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Medley, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Medley, Inc. reported revenues of $61.5M.

Earnings Growth

  • Medley, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Medley, Inc. reported earnings per share of $0.10.
Enterprise value:
491.5M
EV / Invested capital:
2.17x
Price / LTM sales:
1.95x
EV / EBIT:
44.78x
EV / Revenue:
2.08x
PEG ratio (5yr expected):
1.68x
EV / Free cash flow:
15.23x
Price / Operating cash flow:
15.22x
Enterprise value / EBITDA:
17.91x
Gross Profit (TTM):
$150.1M
Return On Assets:
3.44%
Net Income Margin (TTM):
4.43%
Return On Equity:
8.37%
Return On Invested Capital:
4.42%
Operating Margin:
1.65%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $138.5M $176.8M $236.6M $46.5M $61.5M
Gross Profit $91.9M $113.8M $150.1M $28.9M $40M
Operating Income $18.7M $16M $11M $650K $1M
EBITDA $23.3M $24.3M $27.5M $3.5M $5.6M
Diluted EPS $0.50 $0.54 $0.33 $0.06 $0.10
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $163.4M $110M $124.8M $172.5M $108.9M
Total Assets $191.4M $147.4M $168.8M $287.5M $291.8M
Current Liabilities $29.4M $28.6M $40.2M $66.9M $76.9M
Total Liabilities $52.4M $45.2M $51.4M $149.1M $181.4M
Total Equity $139.1M $102.2M $117.4M $138.4M $110.4M
Total Debt $29.6M $18.4M $11.8M $88M $116M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-06-30 2023-06-30 2024-06-30 2023-06-30 2024-06-30
Cash Flow Statement
Cash Flow Operations -- -- -- $20.1M $16.1M
Cash From Investing -- -- -- -$5.9M -$52.3M
Cash From Financing -- -- -- -$2.8M $71.4M
Free Cash Flow -- $36.5M $49M $18.9M $15.2M
MDLYF
Sector
Market Cap
$446.8M
$28.5M
Price % of 52-Week High
62.35%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
-1.4%
-1.33%
1-Year Price Total Return
-37.65%
-20.32%
Beta (5-Year)
--
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $14.24
200-day SMA
Sell
Level $20.49
Bollinger Bands (100)
Sell
Level 15.22 - 21.06
Chaikin Money Flow
Sell
Level --
20-day SMA
Sell
Level $14.56
Relative Strength Index (RSI14)
Sell
Level 0.00
ADX Line
Sell
Level 99.75
Williams %R
Buy
Level -100
50-day SMA
Sell
Level $15.75
MACD (12, 26)
Sell
Level -0.50
25-day Aroon Oscillator
Sell
Level -32
On Balance Volume
Sell
Level -4.3K

Financial Scores

Buy
Altman Z-Score (Annual)
Level (4.2194)
Buy
CA Score (Annual)
Level (0.329)
Sell
Beneish M-Score (Annual)
Level (-1.653)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (0.445)
Sell
Piotroski F Score (Annual)
Level (3)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Medley, Inc. engages in the development and provision of human resource recruitment and telemedicine system services. It operates through the following segments: Human Resources, Medical Platform Business and New Development Services. The Human Resources Platform Business segment operates and provides JobMedley a performance-based recruitment system to resolve issues such as a shortage of human resources and regional uneven distribution in the medical healthcare field, as well as JobMedley academy an online training business in the nursing care field. The Medical Platform Business segment operates and provides the cloud-based medical support system CLINICS, the family pharmacy support system Pharms ??the medical information provision service MEDLEY, the electronic medical record system for hospitals MALL, and the cloud-based dental business support system Dentis, in order to improve the operational efficiency of medical institutions and increase patients' access to medical care. The New Development Service segment include the operation and provision of Kaigo no Honne, a nursing care facility search site for people looking for nursing care facilities, and a factoring service that meets the rapid financing needs of client businesses. The company was founded by Kohei Takiguchi on June 5, 2009 and is headquartered in Tokyo, Japan.

Stock Forecast FAQ

In the current month, MDLYF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MDLYF average analyst price target in the past 3 months is --.

  • Where Will Medley, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Medley, Inc. share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Medley, Inc.?

    Analysts are divided on their view about Medley, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Medley, Inc. is a Sell and believe this share price will rise from its current level to --.

  • What Is Medley, Inc.'s Price Target?

    The price target for Medley, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is MDLYF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Medley, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of MDLYF?

    You can purchase shares of Medley, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Medley, Inc. shares.

  • What Is The Medley, Inc. Share Price Today?

    Medley, Inc. was last trading at $14.24 per share. This represents the most recent stock quote for Medley, Inc.. Yesterday, Medley, Inc. closed at $14.24 per share.

  • How To Buy Medley, Inc. Stock Online?

    In order to purchase Medley, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
50
TGL alert for Dec 8

Treasure Global, Inc. [TGL] is up 29.72% over the past day.

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 46.38% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 9.68% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock